Nicole Christine Bakewell

Recommended Articles

• What is the DASH diet?

  DASH, or Dietary Approaches to Stop Hypertension, is a flexible eating plan developed by experts to lower blood pressure. Although the diet was developed for people with hypertension, it was found to be effective in losing weight, and also in reducing diabetes, metabolic syndrome, and other health...

• What to Expect After a Stroke

  A stroke is a condition in which the brain is deprived of the required blood supply or there is a blood clot formation in a blood vessel in the brain. Strokes can be either caused by internal bleeding (hemorrhagic stroke) or by inadequate blood flow, which can also lead to the death of healthy brain...

• Breast Cancer: A Speaker's Guide

  Many people who experience a life-changing event such as cancer find they want to educate others about their experiences.Sharing experiences with others can raise awareness and can help women to feel empowered—it reminds them they are not alone.If this is true for you, you may choose to “start...

• How is Lactose Intolerance Diagnosed?

  Lactose intolerance has gained a lot of prominence in recent years. The common symptoms of lactose intolerance like bloating, flatulence, discomfort, and diarrhea can often mimic the symptoms of many other medical conditions. There is often a tendency to self-diagnose when observing these symptoms....

• Is My Child More Likely to Develop Autism if a Blood Relative Has Autism?

  Autism characterized by impaired social interactions reduced verbal and non-verbal communication and stereotyped behavior and activities. These symptoms appear in early childhood and impair or limit everyday functioning.Autism and geneticsResearchers believe that both environment and genetics play a...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...